Clinical Trial Update: Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial at Mercy Bon Secours Saint Vincent Medical Center is comparing haloperidol to olanzapine for suspected cannabinoid hyperemesis syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabinoid Hyperemesis Syndrome

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• olanzapine (olanzapine)

Snippet

Sponsor: Mercy Bon Secours Saint Vincent Medical Center | Conditions: Cannabinoid Hyperemesis Syndrome | Phase 3 | Status: RECRUITING